Skip to content

The Efficacy of Transcutaneous Vagus Nerve Stimulation for Alleviating Pain After Video-Assisted Thoracoscopic Pulmonary Lobectomy: A Randomized, Controlled, Double-Blind Interventional Study

The Efficacy of Transcutaneous Vagus Nerve Stimulation for Alleviating Pain After Video-Assisted Thoracoscopic Pulmonary Lobectomy: A Randomized, Controlled, Double-Blind Interventional Study

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400081062
Enrollment
Unknown
Registered
2024-02-21
Start date
2024-03-26
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative pain after video-assisted thoracoscopic pulmonary lobectomy

Interventions

Active stimulation group:The active stimulation group receives active electrical stimulation on the left cymba conchae at a frequency of 30 Hz, pulse width of 250µs, 30s on/30s off, continuously for 3
Sham stimulation group:The sham stimulation group undergoes the same treatment regimen. Sham stimulation involves placing electrodes on the left cymba conchae, adjusting the stimulation intensity usi

Sponsors

Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: ? Age between 18 and 85 years. ? Patients are diagnosed as lung cancer at the Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, and scheduled for video-assisted thoracoscopic pulmonary lobectomy under general anesthesia. ? Voluntarily participate in the study and sign the informed consent form. ? American Society of Anesthesiologists (ASA) classification 1-3. ? Capable of understanding the research procedures, the use of various assessment scales, and effectively communicating with the research team.

Exclusion criteria

Exclusion criteria: ? Patients with arrhythmias which need to treat. ? History of thoracic surgery. ? Patients with neuromuscular disorders or left earlobe dermatitis. ? History of substance abuse, including opioids. ? Patients unable to cooperate with various assessments. ? History of seizures or syncope within the last 5 years. ? Previous transient ischemic attacks or cerebrovascular accidents. ? Patients who received vagus nerve stimulation or acupuncture treatment in the month preceding the study. ? Currently participating in other clinical trials. ? Vulnerable populations, including those with mental illnesses, cognitive impairments, critically ill patients, minors, pregnant women, illiterates, etc.

Design outcomes

Primary

MeasureTime frame
Postoperative 24-hour cumulative consumption of sufentanil ;Postoperative opioid consumption and pain scores.;

Secondary

MeasureTime frame
basis information including height, weight, gender, age, history of hypertension, history of diabetes, and preoperative lung function.;Surgical duration, crystalloid infusion volume, transfusion volume, urine output, time to postoperative extubation, PACU (Post-Anesthesia Care Unit) stay time.;vital signs about blood pressure and heart rate monitoring.;Incidence of rebound pain after nerve blockade.;Postoperative recovery quality; Incidence of chronic pain;complications;

Countries

China

Contacts

Public ContactGang Chen

Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University

chengang120@hotmail.com+86 137 5711 8681

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026